BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Molecular Spectroscopy Market: Key Trends & Regional Prospects

  The global molecular spectroscopy market is expected to observe promising growth across the assessment period of 2020-2030.

  June 18, 2021

   · 

  5 min read
• Rising Incidence of Strokes and Spinal Cord Injuries Spurring the Growth of Rehabilitation Robots Market: Fact.MR

  The global rehabilitation robots market is exhibiting a steady growth due to rising prevalence of stroke, traumatic brain injuries, dementia, and other age-related disabilities.

  June 18, 2021

   · 

  5 min read
• Cluster Headache Syndrome Market: Increasing Global Geriatric Population to Drive the Market

  The global cluster headache syndrome market is foreseen to be advantaged by the advent of new medical equipment and drugs for treatment.

  June 18, 2021

   · 

  6 min read
• Blood Testing Market: Rise in Chronic Diseases to Bolster Demand in the Market

  A blood test refers to the process of blood sample analysis conducted in a laboratory and the blood is generally drawn from a vein in one of the arms using a needle.

  June 18, 2021

   · 

  3 min read
• Adalimumab Market: Rising Occurrence of Arthritis Worldwide to Drive the Market

  Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis.

  June 18, 2021

   · 

  4 min read
• Drug Development

  InnoCare Presents Latest Clinical Data of Orelabrutinib at the16th International Conference on Malignant Lymphoma

  InnoCare, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced the company presented the latest clinical data of the Bruton’s tyrosine kinase inhibitor orelabrutinib at the 16th International Conference on Malignant Lymphoma.

  June 18, 2021

   · 

  2 min read
• ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant Lymphoma

  ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16 th Annual International Conference on Malignant Lymphoma

  June 18, 2021

   · 

  7 min read
• Genetown

  Entasis Therapeutics Introduces First-in-Class Candidate, ETX0462, and Presents Data on SUL-DUR and ETX0282CPDP at World Microbe Forum

  Entasis Therapeutics Holdings Inc. today announced multiple presentations at the World Microbe Forum 2021, taking place virtually June 20-24.

  June 18, 2021

   · 

  4 min read
• Bioelectronica® Corporation Wins Annual CYTO Virtual Interactive 2021 Innovation Showcase

  Bioelectronica ® Corporation announced today that the company won the Innovation Showcase competition that was held at CYTO Virtual Interactive 2021.

  June 18, 2021

   · 

  2 min read
• Biotech Beach

  Patent Issued to IRISYS, LLC for a New Liposomal Anticancer Drug Delivery System

  IRISYS, LLC announced today that it has been issued U.S. Patent No. 11,033,530, Liposomal Anticancer Compositions.

  June 18, 2021

   · 

  2 min read